+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

United States Contrast Media Injectors Market Outlook to 2033 - Computed Tomography (CT) Injectors, Magnetic Resonance Imaging (MRI) Injectors and Angiographic Injectors

  • PDF Icon

    Report

  • 28 Pages
  • July 2025
  • Region: United States
  • GlobalData
  • ID: 6115257
The “United States Contrast Media Injectors Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Contrast Media Injectors market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Computed Tomography (CT) Injectors, Magnetic Resonance Imaging (MRI) Injectors and Angiographic Injectors

The United States Contrast Media Injectors Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Contrast Media Injectors Market.
  • Global corporate-level profiles of key companies operating within the United States Contrast Media Injectors Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Contrast Media Injectors is segmented as follows:

  • Computed Tomography (CT) Injectors
  • Magnetic Resonance Imaging (MRI) Injectors
  • Angiographic Injectors

Reasons to Buy

The United States Contrast Media Injectors Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Contrast Media Injectors Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Contrast Media Injectors Market, United States
3.1 Contrast Media Injectors Market, United States, Revenue ($m), 2018-2033
3.2 Contrast Media Injectors Market, United States, Volume (Units), 2018-2033
3.3 Contrast Media Injectors Market, United States, Average Price ($), 2018-2033
3.4 Contrast Media Injectors Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Contrast Media Injectors Market
4.1 Bracco Imaging SpA
4.1.1 Company Overview
4.2 Bayer AG
4.2.1 Company Overview
4.3 ulrich GmbH & Co KG
4.3.1 Company Overview
4.4 Guerbet SA
4.4.1 Company Overview
4.5 Nemoto Kyorindo Co Ltd
4.5.1 Company Overview
5 Contrast Media Injectors Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029
6.2 Equity Offerings
6.2.1 GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
6.2.2 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares
7 Recent Developments
7.1 Financial Announcements
7.1.1 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025
7.1.2 Apr 07, 2025: LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
7.1.3 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025
7.1.4 Oct 31, 2024: LeMaitre Reports Q3 2024 Results
7.1.5 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
7.1.6 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
7.1.7 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
7.2 Government and Public Interest
7.2.1 Apr 01, 2025: LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
7.2.2 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Contrast Media Injectors Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Contrast Media Injectors Market, United States, Volume (Units), 2018-2033
Table 3: Contrast Media Injectors Market, United States, Average Price ($), 2018-2033
Table 4: Contrast Media Injectors Market, United States, Company Share by Revenue ($m), 2024
Table 5: Contrast Media Injectors Market Pipeline Products
Table 6: GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029
Table 7: GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
Table 8: GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares
Table 9: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country
List of Figures
Figure 1: Contrast Media Injectors Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Contrast Media Injectors Market, United States, Volume (Units), 2018-2033
Figure 3: Contrast Media Injectors Market, United States, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG
  • Bracco Imaging SpA
  • Guerbet SA
  • Nemoto Kyorindo Co Ltd
  • Sino Medical-Device Technology Co., Ltd.
  • ulrich GmbH & Co KG